Niki BioSolutions (NIKI) director Laura Philips discloses 6,024-share holding
Rhea-AI Filing Summary
Niki BioSolutions, Inc. director Laura A. Philips filed an initial ownership report on Form 3. On 2026-07-20 she reported direct beneficial ownership of 6,024 shares of Common Stock of Niki BioSolutions. The filing lists this holding as a baseline position and does not report any buy or sell transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Philips Laura A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 6,024 shares (Direct)
Key Figures
Common shares held: 6,024 shares
Holding entries reported: 1
2 metrics
Common shares held
6,024 shares
Direct holdings of Laura A. Philips reported on Form 3
Holding entries reported
1
Number of non-transactional holding rows in this Form 3
Key Terms
Common Stock, Rule 10b5-1, Direct/Indirect ownership type
3 terms
Common Stock financial
""security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Rule 10b5-1 regulatory
"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Direct/Indirect ownership type financial
"direct_or_indirect uses D/I for Direct/Indirect ownership type"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Form 3 filing for Niki BioSolutions (NIKI) report?
The Form 3 reports that director Laura A. Philips holds 6,024 shares of Niki BioSolutions Common Stock. It is an initial ownership statement and does not disclose any purchase or sale transactions.
Is Laura A. Philips’ reported Niki BioSolutions (NIKI) ownership direct or indirect?
The Form 3 shows her 6,024 shares as direct ownership, using the ownership code "D". No indirect holdings through trusts or other entities are listed in this filing.
Does the Niki BioSolutions (NIKI) Form 3 show any recent insider trades?
No. The Form 3 includes a holding entry with no transaction code and shows 6,024 shares held. The transaction summary records one holding entry and no buy or sell share activity.
Who is the reporting person in the Niki BioSolutions (NIKI) Form 3?
The reporting person is Laura A. Philips, who is identified in the filing as a director of Niki BioSolutions, Inc. She reports direct beneficial ownership of 6,024 Common Stock shares.